FGFR amplification has been frequently reported in lung squamous cell carcinoma (SqCC, 5.6%–24.8%), small cell lung cancers (SCLC, 5.6%–6%), estrogen receptor‐positive breast cancers (10%), and ovary (~5%) and bladder (<2%) cancers. The gene discussed is ESR1; the disease is small cell lung carcinoma.